Thromboprophylaxis
Showing 1 - 25 of 334
Germ Cell Tumor Trial (Thromboprophylaxis)
Not yet recruiting
- Germ Cell Tumor
- Thromboprophylaxis
- (no location specified)
May 16, 2023
Women's Preferences for Postpartum Thromboprophylaxis:
Completed
- Venous Thromboembolism
- Pregnancy Related
- Interview
-
Paris, France
- +1 more
Jun 9, 2023
Hip Fractures Trial in Calgary (Rivaroxaban 10mg, acetylsalicylic acid (ASA) 81mg Oral Tablet)
Not yet recruiting
- Hip Fractures
- Rivaroxaban 10mg
- acetylsalicylic acid (ASA) 81mg Oral Tablet
-
Calgary, Alberta, CanadaFoothills Medical Centre
Mar 7, 2023
Venous Thromboembolism, Arthroplasty Trial in Chiayi City (Rivaroxaban 10 MG)
Recruiting
- Venous Thromboembolism
- Arthroplasty
- Rivaroxaban 10 MG
-
Chiayi City, TaiwanDitmanson Medical Foundation Chiayi Christian Hospital
Dec 20, 2022
Venous Thromboembolism, Varicose Veins Trial in London (Dalteparin Sodium, Tinzaparin Sodium, Enoxaparin Sodium)
Not yet recruiting
- Venous Thromboembolism
- Varicose Veins
- Dalteparin Sodium
- +5 more
-
London, United KingdomImperial College Hospital NHS Foundation Trust
Feb 20, 2023
Trauma Injury, Thromboembolism, Venous Thromboembolism Trial in Houston (Thrombate infusion, Placebo)
Not yet recruiting
- Trauma Injury
- +2 more
- Thrombate infusion
- Placebo
-
Houston, TexasThe University of Texas Health Science Center at Houston
Mar 28, 2023
Thromboprophylaxis Appropriateness in Hospitalized Medical
Recruiting
- Deep Vein Thrombosis
- +2 more
-
Baghdad, IraqEUC
Oct 21, 2022
Morbid Obesity Trial in Erbil (Bemiparin 3500, Bemiparin 5000 IU)
Recruiting
- Morbid Obesity
- Bemiparin 3500
- Bemiparin 5000 IU
-
Erbil, Kurdistan Region, IraqHawler Medical university
Jan 8, 2023
Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,
Not yet recruiting
- Kawasaki Disease
- +4 more
- Rivaroxaban Oral Tablet or Suspension [Xarelto]
- +2 more
- (no location specified)
Dec 6, 2022
Liver Cancer, Surgery, Thrombosis, Deep Vein Trial in Finland, Norway (enoxaparin or tinzaparin or dalteparin, No intervention)
Recruiting
- Liver Cancer
- +4 more
- enoxaparin or tinzaparin or dalteparin
- No intervention
-
Helsinki, Finland
- +5 more
Sep 21, 2022
Pregnancy Trial in Paris (standard-gamble technique, time trade-off technique)
Recruiting
- Pregnancy
- standard-gamble technique
- time trade-off technique
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Jun 29, 2022
Pancreas Cancer, Pancreas Tumor, Surgery Trial (enoxaparin/tinzaparin/dalteparin)
Not yet recruiting
- Pancreas Cancer
- +4 more
- (no location specified)
Feb 8, 2022
IBD, Venous Thromboembolism, Crohn Disease Trial in Hamilton (Apixaban 2.5 milligram, Placebo Oral Tablet)
Recruiting
- IBD
- +5 more
- Apixaban 2.5 milligram
- Placebo Oral Tablet
-
Hamilton, Ontario, Canada
- +1 more
Aug 26, 2022
Anticoagulants; Increased Trial (catheter induced thromboprophylaxis)
Not yet recruiting
- Anticoagulants; Increased
- catheter induced thromboprophylaxis
- (no location specified)
Jan 21, 2023
Venous Thromboembolism Trial in Geneva, Lugano (Comprehensive electronic tool in the electronic medical chart, Educative
Recruiting
- Venous Thromboembolism
- Comprehensive electronic tool in the electronic medical chart
- +2 more
-
Geneva, Switzerland
- +1 more
Mar 22, 2022
Pancreatic Cancer, Thromboembolism Trial in Athens (Innohep, Chemotherapy: Gemcitabine + Nab-Paclitaxel)
Recruiting
- Pancreatic Cancer
- Thromboembolism
- Innohep
- Chemotherapy: Gemcitabine + Nab-Paclitaxel
-
Athens, Attiki, Greece
- +1 more
Mar 28, 2022
Thromboprophylaxis, Thromboembolism, Venous, Atrial Fibrillation Trial in Pamplona (Triaxial accelerometry)
Recruiting
- Thromboprophylaxis
- +4 more
- Triaxial accelerometry
-
Pamplona, Navarra, SpainHospital Universitario de Navarra
Oct 29, 2023
Acute Coronary Syndrome Trial in Shatin (CSL112, Placebo)
Not yet recruiting
- Thromboembolism
- No intervention as this is an observational study
-
Shatin, Hong KongThe Chinese University of Hong Kong
Nov 1, 2022
Thromboprophylaxis by Low Molecular Heparin During Post-partum
Recruiting
- Thromboembolic Disease
- medical data collection
-
Corbeil-essonnes Cedex, FranceCentre Hospitalier Sud Francilien
Nov 9, 2021
Aspirin Thromboprophylaxis After First-line Total Hip and Knee
Recruiting
- Hip and Knee Prosthesis Implantation
-
Strasbourg, FranceService de Chirurgie Orthopédique Pédiatrique - Hôpitaux Univers
Nov 23, 2021
Pregnancy Related, Antepartum DVT Trial in Los Angeles (Standard Dose of Unfractionated Heparin, Gestational Age-Based Dose of
Completed
- Pregnancy Related
- Antepartum DVT
- Standard Dose of Unfractionated Heparin
- Gestational Age-Based Dose of Unfractionated Heparin
-
Los Angeles, CaliforniaUCLA Medical Center
Jun 29, 2022
Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],
Recruiting
- Myeloproliferative Neoplasm
- +5 more
- Apixaban 2.5 MG Oral Tablet [ELIQUIS]
- Aspirin 81 mg
-
Ottawa, Ontario, CanadaThe Ottawa Hospital
Apr 19, 2022
Nephrotic Syndrome Trial in Warsaw (Enoxaparin)
Terminated
- Nephrotic Syndrome
-
Warsaw, Masovian District, PolandMilitary Institute of Medicine
Jan 26, 2023
Venous Thromboembolism, Cancer Trial (Rivaroxaban 10 MG)
Not yet recruiting
- Venous Thromboembolism
- Cancer
- Rivaroxaban 10 MG
- (no location specified)
Aug 25, 2021